We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Bryan Johnson, the American entrepreneur renowned for his anti-ageing endeavours, has disclosed the details of his latest ...

depression and anxiety. Diagnosing and treating IBD is also challenging, says Dr. Louis Ghanem, director of immunology, translational science and medicine at Johnson & Johnson. Ghanem says this is ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Johnson's passion for helping others led her ... didn’t think she was smart or worthy or worth being loved … suffering from depression and suicidal ideation – I would say to that little ...

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.

Many Indians laid low by disease have turned to biohacking. Others are healthy but want to live longer. Aiding them in their ...

Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is ...

Mr Johnson is an American entrepreneur and venture ... of Latter-day Saints when he was 24 after falling into a deep depression that lasted 10 years. He said in an August 2023 interview on The ...